Marcela V Maus
Marcela V Maus
Harvard Medical School
Dirección de correo verificada de mgh.harvard.edu
TítuloCitado porAño
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
GP Linette, EA Stadtmauer, MV Maus, AP Rapoport, BL Levine, L Emery, ...
Blood 122 (6), 863-871, 2013
6492013
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
MV Maus, SA Grupp, DL Porter, CH June
Blood, The Journal of the American Society of Hematology 123 (17), 2625-2635, 2014
6152014
CD8+ T-cell responses to adeno-associated virus capsid in humans
F Mingozzi, MV Maus, DJ Hui, DE Sabatino, SL Murphy, JEJ Rasko, ...
Nature medicine 13 (4), 419, 2007
5362007
Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce antitumor activity in solid malignancies
GL Beatty, AR Haas, MV Maus, DA Torigian, MC Soulen, G Plesa, ...
Cancer immunology research 2 (2), 112-120, 2014
4822014
Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB
MV Maus, AK Thomas, DGB Leonard, D Allman, K Addya, K Schlienger, ...
Nature biotechnology 20 (2), 143, 2002
4762002
Chimeric antigen receptor T cells against CD19 for multiple myeloma
AL Garfall, MV Maus, WT Hwang, SF Lacey, YD Mahnke, JJ Melenhorst, ...
New England Journal of Medicine 373 (11), 1040-1047, 2015
3762015
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cells
M Oelke, MV Maus, D Didiano, CH June, A Mackensen, JP Schneck
Nature medicine 9 (5), 619, 2003
3212003
T cells expressing chimeric antigen receptors can cause anaphylaxis in humans
MV Maus, AR Haas, GL Beatty, SM Albelda, BL Levine, X Liu, Y Zhao, ...
Cancer immunology research 1 (1), 26-31, 2013
3112013
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
DM O’Rourke, MLP Nasrallah, A Desai, JJ Melenhorst, K Mansfield, ...
Science translational medicine 9 (399), eaaa0984, 2017
2842017
Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma
LA Johnson, J Scholler, T Ohkuri, A Kosaka, PR Patel, SE McGettigan, ...
Science translational medicine 7 (275), 275ra22-275ra22, 2015
2602015
Adoptive immunotherapy for cancer or viruses
MV Maus, JA Fraietta, BL Levine, M Kalos, Y Zhao, CH June
Annual review of immunology 32, 189-225, 2014
2082014
4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy
H Zhang, KM Snyder, MM Suhoski, MV Maus, V Kapoor, CH June, ...
The Journal of Immunology 179 (7), 4910-4918, 2007
1732007
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
JA Fraietta, KA Beckwith, PR Patel, M Ruella, Z Zheng, DM Barrett, ...
Blood 127 (9), 1117-1127, 2016
1632016
Making better chimeric antigen receptors for adoptive T-cell therapy
MV Maus, CH June
Clinical Cancer Research 22 (8), 1875-1884, 2016
1492016
Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors
GC Pien, E Basner-Tschakarjan, DJ Hui, AN Mentlik, JD Finn, ...
The Journal of clinical investigation 119 (6), 1688-1695, 2009
1352009
A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes
AK Thomas, MV Maus, WS Shalaby, CH June, JL Riley
Clinical Immunology 105 (3), 259-272, 2002
1312002
Prolactin as a chemoattractant for human breast carcinoma
MV Maus, SC Reilly, CV Clevenger
Endocrinology 140 (11), 5447-5450, 1999
1311999
Chimeric antigen receptor T cell therapy: 25 years in the making
S Gill, MV Maus, DL Porter
Blood reviews 30 (3), 157-167, 2016
1162016
Engineered T cells for cancer therapy
CH June, MV Maus, G Plesa, LA Johnson, Y Zhao, BL Levine, SA Grupp, ...
Cancer Immunology, Immunotherapy 63 (9), 969-975, 2014
1012014
ASBMT consensus grading for cytokine release syndrome and neurological toxicity associated with immune effector cells
DW Lee, BD Santomasso, FL Locke, A Ghobadi, CJ Turtle, JN Brudno, ...
Biology of Blood and Marrow Transplantation, 2018
992018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20